Financial & Business News
LATEST INVESTING HEADLINES
American tower was a REIT on my no-no-list for several years after starting to write as a contributor. While others considered it undervalued back in 2019 and 2020, I didn't. I did not become interested in AMT until mid-2022, bought a few shares, and am now more interested in slowly expanding my position.
It could be value's time to shine for the first time in years.
A weaker ad market is hurting Roku, with sales in Q4 unchanged year over year. Roku was still able to post gains in its three key performance metrics in 2022.
Reata Pharmaceuticals stock is soaring on the back of a recent FDA approval for a new rare disease drug. Calliditas Therapeutics stock recently jumped higher in response to positive trial results for its lead drug.
Stellantis' P/E is lower than its Detroit competitors, despite outearning them. Some of that is due to its EV strategy compared to its rivals, which worries some investors.
From Manifest Destiny to Big Tech, Silicon Valley Bank's crash is a case study in the how the West was spun.
Realty Income is a highly defensive REIT. AGNC Investment has a high yield, but a lot rides on the behavior of the Fed.
Some sectors fare better than others when inflation is high. Physical assets such as gold and real estate often hold their relative value when dollars don't.
The strategy risks hurting innovation, recruiting, and morale. It also makes it less likely he'll boost productivity or make Meta a talent magnet.
Brookfield Renewable is poised to profit from an unstoppable trend. Dollar General should thrive even if the banking sector's troubles worsen.